Recent studies have also demonstrated that some interferon-stimulated genes (ISGs) are significantly down-regulated in blood T cells and B cells of patients with melanoma, breast cancer and gastrointestinal cancer [34], [35]. This evidence concerns the gene STING1 and melanoma.